Close Menu

NEW YORK (GenomeWeb) – T2 Biosystems said today that it has received CE marking for its T2Bacteria Panel, enabling the sale and distribution of the product within the European Union countries and others accepting the mark.

The bacteria panel will be commercially available as part of the T2Sepsis Solution in Europe in the third quarter of 2017, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.